European Recovery Strengthens According to PMI (Reuters)
New manufacturing orders increased for the fourth month in a row in the European Community, according to the October Manufacturing Purchasing Managers’ Index (PMI). The final PMI for October rose to 51.3 from September’s 51.1, in line with analysts’ estimates, and well above the 50 level that indicates growth in manufacturing. However, the PMI figure could have been even stronger had not the French economy contracted for October. Even though the 17-bloc nation’s factory production was re-approaching its most recent 26-month high recorded in August, it still trailed historic levels. For investors though, any news is good news, as far as Europe is concerned.
It was a flattish week for global stock markets last week with the Dow Jones up 0.29% and the S&P 500 rising 0.11%. The MCSI Emerging Markets Index ended the week 0.63% lower.
The story of the week in your Bull Market Alert portfolio was Gentherm (THRM), which soared 13.04% on better-than-expected earnings. In Friday's special alert, I recommended that you tighten your stop to $22.55 to lock in at least a 20% gain in the stock.
Today, I'm also recommending that you rai
Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:
Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.
Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:
Exclusive Report: 3 Biotech Breakthroughs To Bank On
Where does the Smart Money look for the best biotech stocks? Small- and mid-cap biotechs. They're the ones with the ability to transform the world, and bring investors transformational profits. To get free access to Hilary Kramer's latest report, 3 Biotech Breakthroughs To Bank On, simply tell us where to send it in the box below.
*Along with my FREE report, Hilary Kramer's 3 Biotech Breakthroughs to Bank On, please also send Hilary's free weekly e-letter, Trading Desk. We value your privacy. You will not be spammed, ever. Period.